Skip to content
10-Q

Quarterly Report

BioCorRx Inc. BICX

0001477932-25-003828

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 14, 2025 17M sh
Stockholders Equity Q1 2024 · Mar 31, 2025 −$11.56M
Stockholders Equity Q1 2024 · Dec 31, 2024 −$12.12M
Current Liabilities Q1 2024 · Mar 31, 2025 $13.44M
Current Liabilities Q1 2024 · Dec 31, 2024 $8.21M
Total Liabilities Q1 2024 · Mar 31, 2025 $18.6M
Total Liabilities Q1 2024 · Dec 31, 2024 $12.74M
Current Assets Q1 2024 · Mar 31, 2025 $565.8K
Current Assets Q1 2024 · Dec 31, 2024 $118K
Total Assets Q1 2024 · Mar 31, 2025 $6.8M
Total Assets Q1 2024 · Dec 31, 2024 $385.94K
Shares Diluted Q1 2024 · Mar 31, 2024 2.94M sh
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$339.67K
Sga Expense Q1 2024 · Mar 31, 2024 $750.1K
Rd Expense Q1 2024 · Mar 31, 2024 $213.83K
Net Income restated Q1 2024 · Mar 31, 2024 −$1.24M
Operating Income Q1 2024 · Mar 31, 2024 −$968.69K
Cost Of Revenue Q1 2024 · Mar 31, 2024 $1.67K
Revenue Q1 2024 · Mar 31, 2024 $3.62K